Subtitles are available in English and other languages. They are automatically generated using AI, so some errors may occur.
Major Late-Breaking Trials from EuroPCR 2025
Other coronary interventions
Other valvular and structural interventions
Hotline / Late-Breaking Trials
Theatre Bleu
Anchorperson: Bernard Prendergast
Spokesperson: Thomas Cuisset
Discussants: Davide Capodanno, David Moliterno, Gilles Montalescot, Stephan Windecker
Introduction
Bernard Prendergast
Tribute to Jean-Philippe Collet
Meta-Analysis of individual patient data from the PROTECTED TAVR and BHF PROTECT-TAVI studies
Rajesh Kharbanda
Study insights
Davide Capodanno
Discussion and audience interaction
Clinical impact
Davide Capodanno
Angiography versus physiology-guided PCI in patients undergoing TAVI: the functional assessment in TAVI (FAITAVI) trial
Flavio Luciano Ribichini
Study insights
Stephan Windecker
Discussion and audience interaction
Clinical impact
Stephan Windecker
One-month DAPT followed by dose reduction of prasugrel after drug-coated stent insertion in Acute Coronary Syndrome
Woong Chol Kang
Study insights
Gilles Montalescot
Discussion and audience interaction
Clinical impact
Gilles Montalescot
Conclusion
Thomas Cuisset